Aurora and Curaleaf Trade Barbs in Hostile Takeover Battle

M&A · Partnership
โดย Yahoo Finance·USCA·Read original
Summary · why it matters

The hostile takeover battle between Curaleaf and Aurora has escalated as both companies publicly trade accusations. Curaleaf, which has made a $4 per share offer worth about $272 million, published a rebuttal to Aurora's directors' circular urging shareholders to reject the bid. Curaleaf's CEO Boris Jordan accused Aurora of misleading narratives and failing to engage in negotiations, while Aurora's CEO Miguel Martin urged shareholders to focus on the value they already own. Aurora highlights its $149 million in cash and no debt, contrasting with Curaleaf's roughly $1 billion in debt and lease liabilities. Curaleaf argues its offer represents a 45% premium, or 110% excluding Aurora's cash, and notes that Aurora insiders own about 1% of the company but could receive roughly 10% of the deal value. The bid, open since Aug. 18, expires Dec. 1, and the core of the deal is Aurora's EU-GMP certified facilities for exporting cannabis to European medical markets.

Impact on stocks 3

Health Care▼ · 1 stocks
Aurora Cannabis Inc
ACB
▼ NegativeCapitalrelevance

Aurora is the target of a hostile takeover bid at $4/share, with Curaleaf highlighting its debt and urging rejection.

Cloud & Digital Infrastructure▲ · 1 stocks
Artificial Intelligence▲ · 1 stocks

Off-coverage companies 1

Curaleaf HoldingsPrivate▲ Positive
Capitalrelevance

Curaleaf is pursuing a hostile takeover of Aurora, offering a 45% premium and expanding into EU medical cannabis markets.

© 2026 MarketDXNews